Abstract
The in vitro activity of three macrolides, azithromycin, clarithromycin and erythromycin and a new fluoroquinolone, lomefloxacin, against pathogenic mycoplasma (16 to 18 strains ofMycoplasma pneumoniae, 41 to 77 strains ofMycoplasma hominis, 65 to 104 strains ofUreaplasma urealyticum) was compared. The three macrolides were highly active againstMycoplasma pneumoniae. Clarithromycin was the most active macrolide againstUreaplasma urealyticum whereas azithromycin was somewhat more active than erythromycin againstMycoplasma hominis. Lomefloxacin was moderately active against all three mycoplasma species.
Similar content being viewed by others
References
Waites KB, Cassell GH, Canup KC, Fernandes PB: In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. Antimicrobial Agents and Chemotherapy 1988, 32: 1500–1502.
Rylander M, Hallander HO: In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide CP-62,993, againstMycoplasma pneumoniae, Mycoplasma hominis andUreaplasma urealyticum. Scandinavian Journal of Infectious Diseases 1988, Supplement 3: 12–17.
Bébéar C, Cantet P, Renaudin H, Quentin C: Activité comparée de la minocycline et de la doxycycline sur les mycoplasmes pathogènes pour l'homme. Pathologie Biologie 1985, 33: 577–580.
Bébéar C, de Barbeyrac B, Bernet C, Renaudin H: Méthodes d'exploration des infections à mycoplasmes. Annales de Biologie Clinique 1989, 47: 415–420.
Kenny GE, Hooton TM, Roberts MC, Cartwright FD, Hoyt J: Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method. Antimicrobial Agents and Chemotherapy 1989, 33: 103–107.
Cassell GH, Waites KB, Pate MS, Canupp KC, Duffy LB: Comparative susceptibility ofMycoplasma pneumoniae to erythromycin, ciprofloxacin and lomefloxacin. Diagnostic Microbiology and Infectious Diseases 1989, 12: 433–436.
Renaudin H, Quentin C, de Barbeyrac B, Bébéar C: Activité in vitro de nouvelles quinolones sur les mycoplasmes pathogènes pour l'homme. Pathologie Biologie 1988, 36: 496–499.
Bébéar C, Renaudin H, Maugein J, de Barbeyrac B, Clerc M: Pristinamycin and human mycoplasmas: in vitro activity compared with macrolides and lincosamides, in vivo efficacy inMycoplasma pneumoniae experimental infection. Zentralblatt für Bakteriologie 1990, Supplement 20: 77–82.
Benson CA, Segreti J, Beaudette FE, Hines DW, Goodman LJ, Kaplan RL, Trenholme GM: In vitro activity of A-56,268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms. Antimicrobial Agents and Chemotherapy 1987, 31: 328–330.
Jones BM, Kinghorn GR, Duerden BI: In vitro activity of azithromycin and erythromycin against organisms associated with bacterial vaginosis and chancroid. European Journal of Clinical Microbiology and Infectious Diseases 1988, 7: 551–553.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Renaudin, H., Bébéar, C. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin againstMycoplasma pneumoniae, Mycoplasma hominis andUreaplasma urealyticum . Eur. J. Clin. Microbiol. Infect. Dis. 9, 838–841 (1990). https://doi.org/10.1007/BF01967388
Issue Date:
DOI: https://doi.org/10.1007/BF01967388